Author(s): Nasri Hamid | Ghorbani Ali
Journal: Journal of Renal Injury Prevention
ISSN 2345-2781
Volume: 2;
Issue: 2;
Start page: 81;
Date: 2013;
VIEW PDF
DOWNLOAD PDF 
Original page
Keywords: Erythropoietin | Erythropoiesis | Kidney protection | Chronic kidney disease
ABSTRACT
Implication for health policy/practice/research/medical education:The initiation of erythropoietin therapy for the purpose of renoprotection may need to be sooner than that for erythropoiesis, because erythropoietin may attenuate renal fibrosis through macrophage adjustment and endothelial cell protection by other uncertain mechanisms. Although, agents re-establishing the initial function of renal erythropoietin-producing cells could defer kidney fibrosis, however more studies should be carried out to determine the cellular target of erythropoietin in kidney and developinga new erythropoietin derivative for renal care.
Journal: Journal of Renal Injury Prevention
ISSN 2345-2781
Volume: 2;
Issue: 2;
Start page: 81;
Date: 2013;
VIEW PDF
DOWNLOAD PDF Original pageKeywords: Erythropoietin | Erythropoiesis | Kidney protection | Chronic kidney disease
ABSTRACT
Implication for health policy/practice/research/medical education:The initiation of erythropoietin therapy for the purpose of renoprotection may need to be sooner than that for erythropoiesis, because erythropoietin may attenuate renal fibrosis through macrophage adjustment and endothelial cell protection by other uncertain mechanisms. Although, agents re-establishing the initial function of renal erythropoietin-producing cells could defer kidney fibrosis, however more studies should be carried out to determine the cellular target of erythropoietin in kidney and developinga new erythropoietin derivative for renal care.
